Richard N Fedorak, MD - President and Chief Medical Officer
Dr. Richard Fedorak is Professor in the Faculty of Medicine, and Dean, Faculty of Medicine and Dentistry, at the University of Alberta. Dr Fedorak is a recognized international expert in gastrointestinal disorders, as well as a recipient of numerous awards and over $35 million in research fellowships and grants. Dr Fedorak serves on multiple national and international scientific advisory boards and has published over 400 peer-reviewed manuscripts.

David Chang, MASc, PhD - Chief Executive Officer
David Chang has over 15 years' experience managing SMEs, bringing products to market in the emerging field of metabolomics. He has a Masters of Applied Science at the University of Waterloo and a PhD in Chemical and Materials Engineering at the University of Alberta, where he was first involved in the early discoveries of using Nuclear Magnetic Resonance for metabolomics. He has applied his expertise in signal processing, multivariate statistics and modelling to leading-edge biomarker diagnostic applications.David also holds an appointment as an Adjunct Professor in the Faculty of Medicine at the University of Alberta. Before joining MTI in 2015, Dr. Chang was with Chenomx Inc., where he developed and managed business operations.

Haili Wang, MD - Vice President and Chief Scientific Officer
Dr. Haili Wang is a colorectal surgeon and Assistant Professor at the University of Alberta Hospital. She also holds an MSc. in Clinical Epidemiology from the University of Alberta, where her expertise in colorectal cancer led her to the discovery of novel urine diagnostics for improved colorectal cancer screening. Dr. Wang has numerous scientific publications in the area of metabolomics and colorectal cancer surgery.
Lu Deng, PhD -  Senior Scientist and Director of Business Development, Asia
Lu Deng completed her PhD in the Department of Chemistry at the University of Alberta.  Before joining MTI, she was with The Metabolomics Innovation Centre, where she applied her expertise in metabolomics, mass spectrometry, method development and validation to biomarker discovery. Dr. Deng is the recipent of the Canadian National Research Council-IRAP Award for Commercialization for her expertise with mass-spectrometry.

Nicola McFarlane - Director of Business Development, US
Nicola McFarlane has five years of experience in various areas of business development, including market research, marketing and promotion, stakeholder relations and sales and fundraising in the health sector. Before joining MTI, Nicola held positions with BioAlberta and the Li Ka Shing Applied Virology Institute. She holds an MSc. from the Faculty of Medicine and Dentistry at the University of Alberta as well as an MBA specializing in Technology Commercialization from the Alberta School of Business. 

Jean Forsythe, BA - Manager, Corporate Development
Jean Forsythe has over fifteen years' experience in managing projects, including coordinating fundraising campaigns for university development initiatives. Before joining MTI, Jean was the Campaign Coordinator for the Hoover Institution at Stanford University. She has a BA from the University of British Columbia.

Randy Yatscoff (TEC Edmonton) - Business Development Team
TEC Edmonton is a business service provider, helping transform technologies into business opportunities. TEC Edmonton helps navigate the commercialization process - transitioning science solutions into business opportunities with a goal to capture the value of the innovation in our region, and for our region. The unique not-for-profit TEC Edmonton is a joint venture between the University of Alberta and the Edmonton Economic Development Corporation (EEDC).